Capricor Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) Transcript
Good afternoon, everyone, and thank you for tuning in today to H.C. Wainwright 2022 Global Investment Hybrid Conference. My name is Trevor Levy, and I am on the corporate access team at H.C. Wainwright. And now I'm pleased to welcome our presenter, AJ Bergmann, the Chief Financial Officer of Capricor Therapeutics.
Thanks, Trevor, and thanks to Wainwright for hosting. I'm not in attendance, obviously, in Miami, I wish I was. I'm in partly cloudy San Diego. Again, my name is AJ Bergmann. I'm the Chief Financial Officer at Capricor Therapeutics. I have been with the company approximately 10 years. Capricor is a small San Diego-based biotechnology company. Our ticker symbol is CAPR, and we are listed on the NASDAQ.
Let me give a overview of pretty much everything on this slide, but just to bring fully up to [seed] on where we are as a company. Whether this is the many presentation you've heard of Capricor or one of your first, we are focused on the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |